South & Central America Drug Delivery Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End Users)
The South & Central America drug delivery market is expected to grow from US$ 1,09,189.07 million in 2023 to US$ 1,42,876.69 million by 2028. It is estimated to grow at a CAGR of 5.5% from 2023 to 2028.
Growing Demand for Noninvasive Drug Delivery Systems Fuel South & Central America Drug Delivery Market
Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.
A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.
Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.
South & Central America Drug Delivery Market Overview
The South & Central America drug delivery market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies, increasing incidences of chronic diseases, and a rising geriatric population.
South & Central America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Drug Delivery Market Segmentation
The South & Central America drug delivery market is segmented into route of administration, distribution channel, end user, and country.
Based on route of administration, the South & Central America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the South & Central America drug delivery market in 2023.
Based on distribution channel, the South & Central America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the South & Central America drug delivery market in 2023.
Based on end user, the South & Central America drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the South & Central America drug delivery market in 2023.
Based on country, the South & Central America drug delivery market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the share of the South & Central America drug delivery market in 2023.
Bausch Health Companies Inc, Baxter International Inc, Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Novo Nordisk AS, and Pfizer Inc are the leading companies operating in the South & Central America drug delivery market.
Growing Demand for Noninvasive Drug Delivery Systems Fuel South & Central America Drug Delivery Market
Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.
A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.
Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.
South & Central America Drug Delivery Market Overview
The South & Central America drug delivery market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies, increasing incidences of chronic diseases, and a rising geriatric population.
South & Central America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Drug Delivery Market Segmentation
The South & Central America drug delivery market is segmented into route of administration, distribution channel, end user, and country.
Based on route of administration, the South & Central America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the South & Central America drug delivery market in 2023.
Based on distribution channel, the South & Central America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the South & Central America drug delivery market in 2023.
Based on end user, the South & Central America drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the South & Central America drug delivery market in 2023.
Based on country, the South & Central America drug delivery market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the share of the South & Central America drug delivery market in 2023.
Bausch Health Companies Inc, Baxter International Inc, Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Novo Nordisk AS, and Pfizer Inc are the leading companies operating in the South & Central America drug delivery market.
1. INTRODUCTION
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Drug Delivery Market – by Route of Administration
1.3.2 South & Central America Drug Delivery Market – by Distribution Channel
1.3.3 South & Central America Drug Delivery Market – by End User
1.3.4 South & Central America Drug Delivery Market – by Country
2. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis
6. DRUG DELIVERY MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Drug Delivery Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY ROUTE OF ADMINISTRATION
7.1 Overview
7.2 South & Central America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
7.3.1 Overview
7.3.2 Injectable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Conventional Injection Devices
7.3.2.1.1 Overview
7.3.2.1.2 Conventional Injection Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Advanced Devices
7.3.2.2.1 Overview
7.3.2.2.2 Advanced Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
7.4.1 Overview
7.4.2 Oral Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Solid Oral Drugs
7.4.2.1.1 Overview
7.4.2.1.2 Solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Liquid Oral Drugs
7.4.2.2.1 Overview
7.4.2.2.2 Liquid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Semi-solid Oral Drugs
7.4.2.3.1 Overview
7.4.2.3.2 Semi-solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Semi-solid Topical Drug Delivery
7.5.2.1.1 Overview
7.5.2.1.2 Semi-solid Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Liquid Topical Drug Delivery Formulations
7.5.2.2.1 Overview
7.5.2.2.2 Liquid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Solid Topical Drug Delivery Formulations
7.5.2.3.1 Overview
7.5.2.3.2 Solid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Transdermal
7.5.2.4.1 Overview
7.5.2.4.2 Transdermal Patches: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
7.6.1 Overview
7.6.2 Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Pulmonary and Nasal Drug Delivery
7.6.2.1.1 Overview
7.6.2.1.2 Pulmonary and Nasal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.2 Buccal and Sublingual Drug Delivery
7.6.2.2.1 Overview
7.6.2.2.2 Buccal and Sublingual Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.3 Rectal Transmucosal Drug Delivery
7.6.2.3.1 Overview
7.6.2.3.2 Rectal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.4 Vaginal Transmucosal Drug Delivery
7.6.2.4.1 Overview
7.6.2.4.2 Vaginal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
7.7.1 Overview
7.7.2 Implantable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
7.8.1 Overview
7.8.2 Ocular Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Eye Drops and Sprays
7.8.2.1.1 Overview
7.8.2.1.2 Eye Drops and Sprays: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.2 Gels and Ointments
7.8.2.2.1 Overview
7.8.2.2.2 Gels and Ointments: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.3 Ocular Inserts and Punctal Plugs
7.8.2.3.1 Overview
7.8.2.3.2 Ocular Inserts and Punctal Plugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.4 Therapeutic Contact Lens
7.8.2.4.1 Overview
7.8.2.4.2 Therapeutic Contact Lens: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY DISTRIBUTION CHANNEL
8.1 Overview
8.2 South & Central America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 South & Central America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
9.5.1 Overview
9.5.2 Other End User: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 South & Central America Drug Delivery Market, by Country, 2022 & 2028 (%)
10.1.1.1 Brazil: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.1.3.1 Brazil: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.2 Brazil: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.3 Brazil: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.4 Brazil: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.5 Brazil: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.4 Brazil: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.1.5 Brazil: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 Argentina: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.2.3.1 Argentina: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.2 Argentina: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.3 Argentina: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.4 Argentina: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.5 Argentina: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.4 Argentina: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.2.5 Argentina: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 Rest of South & Central America: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.3.3.1 Rest of South & Central America: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.2 Rest of South & Central America: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.3 Rest of South & Central America: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.4 Rest of South & Central America: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.5 Rest of South & Central America: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.4 Rest of South & Central America: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.3.5 Rest of South & Central America: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
11. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in South & Central America Drug Delivery Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Becton Dickinson and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Baxter International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Gerresheimer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GlaxoSmithKline Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.5.1 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Boehringer Ingelheim International GmbH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novartis AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Sever Pharma Solutions
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Johnson & Johnson
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Pfizer Inc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Drug Delivery Market – by Route of Administration
1.3.2 South & Central America Drug Delivery Market – by Distribution Channel
1.3.3 South & Central America Drug Delivery Market – by End User
1.3.4 South & Central America Drug Delivery Market – by Country
2. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis
6. DRUG DELIVERY MARKET – SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Drug Delivery Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY ROUTE OF ADMINISTRATION
7.1 Overview
7.2 South & Central America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
7.3.1 Overview
7.3.2 Injectable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Conventional Injection Devices
7.3.2.1.1 Overview
7.3.2.1.2 Conventional Injection Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Advanced Devices
7.3.2.2.1 Overview
7.3.2.2.2 Advanced Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
7.4.1 Overview
7.4.2 Oral Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Solid Oral Drugs
7.4.2.1.1 Overview
7.4.2.1.2 Solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Liquid Oral Drugs
7.4.2.2.1 Overview
7.4.2.2.2 Liquid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Semi-solid Oral Drugs
7.4.2.3.1 Overview
7.4.2.3.2 Semi-solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Semi-solid Topical Drug Delivery
7.5.2.1.1 Overview
7.5.2.1.2 Semi-solid Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Liquid Topical Drug Delivery Formulations
7.5.2.2.1 Overview
7.5.2.2.2 Liquid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Solid Topical Drug Delivery Formulations
7.5.2.3.1 Overview
7.5.2.3.2 Solid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Transdermal
7.5.2.4.1 Overview
7.5.2.4.2 Transdermal Patches: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
7.6.1 Overview
7.6.2 Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Pulmonary and Nasal Drug Delivery
7.6.2.1.1 Overview
7.6.2.1.2 Pulmonary and Nasal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.2 Buccal and Sublingual Drug Delivery
7.6.2.2.1 Overview
7.6.2.2.2 Buccal and Sublingual Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.3 Rectal Transmucosal Drug Delivery
7.6.2.3.1 Overview
7.6.2.3.2 Rectal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.4 Vaginal Transmucosal Drug Delivery
7.6.2.4.1 Overview
7.6.2.4.2 Vaginal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
7.7.1 Overview
7.7.2 Implantable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
7.8.1 Overview
7.8.2 Ocular Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Eye Drops and Sprays
7.8.2.1.1 Overview
7.8.2.1.2 Eye Drops and Sprays: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.2 Gels and Ointments
7.8.2.2.1 Overview
7.8.2.2.2 Gels and Ointments: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.3 Ocular Inserts and Punctal Plugs
7.8.2.3.1 Overview
7.8.2.3.2 Ocular Inserts and Punctal Plugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.4 Therapeutic Contact Lens
7.8.2.4.1 Overview
7.8.2.4.2 Therapeutic Contact Lens: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY DISTRIBUTION CHANNEL
8.1 Overview
8.2 South & Central America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 South & Central America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
9.5.1 Overview
9.5.2 Other End User: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 South & Central America Drug Delivery Market, by Country, 2022 & 2028 (%)
10.1.1.1 Brazil: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.1.3.1 Brazil: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.2 Brazil: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.3 Brazil: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.4 Brazil: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.5 Brazil: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.4 Brazil: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.1.5 Brazil: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 Argentina: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.2.3.1 Argentina: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.2 Argentina: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.3 Argentina: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.4 Argentina: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.5 Argentina: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.4 Argentina: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.2.5 Argentina: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 Rest of South & Central America: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.3.3.1 Rest of South & Central America: South & Central America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.2 Rest of South & Central America: South & Central America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.3 Rest of South & Central America: South & Central America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.4 Rest of South & Central America: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.5 Rest of South & Central America: South & Central America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.4 Rest of South & Central America: South & Central America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.3.5 Rest of South & Central America: South & Central America Drug Delivery Market, by End User, 2020-2028 (US$ Million)
11. SOUTH & CENTRAL AMERICA DRUG DELIVERY MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in South & Central America Drug Delivery Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Becton Dickinson and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Baxter International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Gerresheimer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GlaxoSmithKline Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.5.1 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Boehringer Ingelheim International GmbH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novartis AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Sever Pharma Solutions
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Johnson & Johnson
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Pfizer Inc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina: South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina: South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina: South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 13. Argentina: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 14. Argentina: South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 15. Argentina: South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 16. Argentina: South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of South & Central America: South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of South & Central America: South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of South & Central America: South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of South & Central America: South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of South & Central America: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of South & Central America: South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of South & Central America: South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of South & Central America: South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Organic Growth Strategies in South & Central America Drug Delivery Market
Table 26. Recent Inorganic Growth Strategies in the South & Central America Drug Delivery Market
Table 27. Glossary of Terms, South & Central America Drug Delivery Market
Table 1. Brazil: South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina: South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina: South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina: South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 13. Argentina: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 14. Argentina: South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 15. Argentina: South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 16. Argentina: South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of South & Central America: South & Central America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of South & Central America: South & Central America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of South & Central America: South & Central America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of South & Central America: South & Central America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of South & Central America: South & Central America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of South & Central America: South & Central America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of South & Central America: South & Central America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of South & Central America: South & Central America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Organic Growth Strategies in South & Central America Drug Delivery Market
Table 26. Recent Inorganic Growth Strategies in the South & Central America Drug Delivery Market
Table 27. Glossary of Terms, South & Central America Drug Delivery Market
LIST OF FIGURES
Figure 1. South & Central America Drug Delivery Market Segmentation
Figure 2. South & Central America Drug Delivery Market by Country
Figure 3. South & Central America Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in South & Central America Drug Delivery Market
Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Drug Delivery Market– Revenue Forecast and Analysis – 2020–2028
Figure 10. South & Central America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 11. Injectable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Conventional Injection Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Advanced Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oral Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Semi-solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Semi-solid Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Liquid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Solid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Transdermal Patches: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pulmonary Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Buccal and Sublingual Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rectal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Vaginal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Implantable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Eye Drops and Sprays: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Gels and Ointments: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ocular Inserts and Punctal Plugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Therapeutic Contact Lens: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. South & Central America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 35. Hospital Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Retail Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Online Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. South & Central America Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
Figure 39. Hospitals and Clinics: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Home Care Settings: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End User: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. South & Central America Drug Delivery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. South & Central America Drug Delivery Market, by Country, 2022 & 2028 (%)
Figure 44. Brazil: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Argentina: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of South & Central America: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Growth Strategies in South & Central America Drug Delivery Market
Figure 1. South & Central America Drug Delivery Market Segmentation
Figure 2. South & Central America Drug Delivery Market by Country
Figure 3. South & Central America Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in South & Central America Drug Delivery Market
Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Drug Delivery Market– Revenue Forecast and Analysis – 2020–2028
Figure 10. South & Central America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 11. Injectable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Conventional Injection Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Advanced Devices: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oral Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Semi-solid Oral Drugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Semi-solid Topical Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Liquid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Solid Topical Drug Delivery Formulations: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Transdermal Patches: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pulmonary Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Buccal and Sublingual Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rectal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Vaginal Transmucosal Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Implantable Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Eye Drops and Sprays: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Gels and Ointments: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ocular Inserts and Punctal Plugs: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Therapeutic Contact Lens: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. South & Central America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 35. Hospital Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Retail Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Online Pharmacies: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. South & Central America Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
Figure 39. Hospitals and Clinics: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Home Care Settings: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End User: South & Central America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. South & Central America Drug Delivery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. South & Central America Drug Delivery Market, by Country, 2022 & 2028 (%)
Figure 44. Brazil: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Argentina: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of South & Central America: South & Central America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Growth Strategies in South & Central America Drug Delivery Market
